International Ophthalmology

, Volume 30, Issue 5, pp 531–537 | Cite as

Clinical characteristics of intermediate uveitis in Tunisian patients

  • Moncef Khairallah
  • Kamel Hmidi
  • Sonia Attia
  • Bechir Jelliti
  • Wafa Hasnaoui
  • Sonia Zaouali
  • Salah Jenzeri
  • Salim Ben Yahia
  • Riadh Messaoud
Original Paper


To analyze the pattern of intermediate uveitis (IU) in a referral center in Tunisia, North Africa. A retrospective, descriptive study of 87 consecutive patients (145 eyes) examined at the Department of Ophthalmology of Monastir (Tunisia) from January 1996 to August 2008. All patients underwent an extensive ocular and systemic history, a complete ophthalmic examination, and fluorescein angiography. Standard diagnostic criteria of IU were employed. The mean follow-up period was 43.2 months (range, 4–65 months). The mean age at diagnosis of IU was 29.1 years (range, 5–54 years). The male-to-female ratio was 1:1.6. Both eyes were affected in 58 patients (66.7%). The best-corrected visual acuity at onset of uveitis ranged from light perception to 20/20 (mean, 20/32). The most frequent ocular findings were vitritis (100%), snowballs (53.8%), and retinal vasculitis (28.3%). Concurrent anterior uveitis was noted in 38.6% of affected eyes. Intermediate uveitis was most commonly idiopathic (86.2%). Systemic associations were found in 13.8%; sarcoidosis (9.2%) and multiple sclerosis (2.3%) were the most common systemic diseases. The ocular complications that developed during the follow-up period included cystoid macular edema (39.3%), cataract (31.7%), inflammatory optic disc involvement (26.2%), and glaucoma or ocular hypertension (9%). One hundred-twelve affected eyes (77.2%) had a final visual acuity more than or equal to 20/40. Factors of poor visual outcome were initial VA less than 20/40 (P = 0.00011), CME (P = 0.0016), and vitritis more than 3+ cells (P = 0.023). In a hospital population in Tunisia, intermediate uveitis started frequently at the 3rd decade. This type of uveitis was most commonly idiopathic. Cystoid macular edema and cataract were the most frequent complications. Visual prognosis appeared to be fairly good.


Epidemiology Intermediate uveitis Pars planitis Tunisia North Africa 


  1. 1.
    Nussenblatt RB, Whitcup SM, Palestine AG (2004) Uveitis: fundamentals and clinical practice, 3rd edn. CV Mosby, St. Louis, pp 291–300Google Scholar
  2. 2.
    Bonfioli AA, Damico FM, Curi AL, Orefice F (2005) Intermediate uveitis. Semin Ophthalmol 20(3):147–154CrossRefPubMedGoogle Scholar
  3. 3.
    Singh R, Gupta V, Gupta A (2004) Pattern of uveitis in a referral eye clinic in north India. Indian J Ophthalmol 52(2):121–125PubMedGoogle Scholar
  4. 4.
    Malla OK, Karki DB, Byanju RN, Shrestha S (2004) Intermediate uveitis: a hospital based study. Kathmandu Univ Med J (KUMJ) 2(4):354–359Google Scholar
  5. 5.
    Arellanes-Gracia L, Navarro-Lopez L (2003) Recillas- Gispert C; Pars planitis in the Mexican Mestizo population: ocular findings, treatment, and visual outcome. Ocul Inmunol Inflamm 11(1):53–60CrossRefGoogle Scholar
  6. 6.
    Donaldson MJ, Pulido JS, Herman DC, Diehl N, Hodge D (2007) Pars planitis: a 20-year study of incidence, clinical features, and outcomes. Am J Ophthalmol 144(6):812–817CrossRefPubMedGoogle Scholar
  7. 7.
    Mwanza JC, Kayembe DL (2001) Uveitis in HIV-infected patients. Eur J Ophthalmol 11(1):53–56PubMedGoogle Scholar
  8. 8.
    Kaimbo Wa Kimbo D, Bifuko A, Dernouchamps JP, Missotten L (1998) Chronic uveitis in Kinshasa (D R Congo). Bull Soc Belge Ophtalmol 270:95–100PubMedGoogle Scholar
  9. 9.
    Hamade IH, Al Shamsi HN, Al Dhibi H et al (2009) Uveitis survey in children. Br J Ophthalmol 93(5):569–572CrossRefPubMedGoogle Scholar
  10. 10.
    Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of Uveitis Nomenclature SUN Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140:509–516CrossRefPubMedGoogle Scholar
  11. 11.
    Kraut JA, McCabe CP (1994) The problem of low vision. Definition and common problems. In: Albert DM, Jakobiec FA (eds) Principles and practice of ophthalmology, vol 5. WB Saunders Company, Philadelphia, pp 3664–3666Google Scholar
  12. 12.
    Capone A, Aaberg TM (1994) Intermediate uveitis. In: Albert DM, Jakobiec FA (eds) Principles and practice of ophthalmology, vol 1, chap 26. W.B. Saunders, PhiladelphiaGoogle Scholar
  13. 13.
    Chang JH, Wakefield D (2002) Uveitis: a global perspective. Ocul Immunol Inflamm 10:263–279CrossRefPubMedGoogle Scholar
  14. 14.
    Kazokoglu H, Onal S, Tugal-Tutkun I, Mirza E, Akova Y, Ozyazgan Y, Soylu M, Batioglu F, Apaydin C (2008) Demographic and clinical features of uveitis in tertiary centers in Turkey. Ophthalmic Epidemiol 15(5):285–293CrossRefPubMedGoogle Scholar
  15. 15.
    BenEzra D, Cohen E, Maftzir G (2005) Uveitis in children and adolescents. Br J Ophthalmol 89(4):444–448CrossRefPubMedGoogle Scholar
  16. 16.
    Ortega-Lorrocea G, Arrllanes-Garcia L (1995) Pars planitis: epidemiology and clinical outcome in a large community hospital in Mexico City. Int Ophthalmol 19:117–120CrossRefGoogle Scholar
  17. 17.
    Park DW, Folk JC, Whitcup SM, Polk TD, Kansupada K, Fountain C et al (1998) Phakic patients with cystoid macular edema, retinal periphlebitis, and vitreous inflammation. Arch Ophthalmol 116:1025–1029PubMedGoogle Scholar
  18. 18.
    De Boer J, Berendschot TT, van der Does P, Rothova A (2006) Long-term follow-up of intermediate uveitis in children. Am J Ophthalmol 141(4):616–621CrossRefPubMedGoogle Scholar
  19. 19.
    Vidovic Valentincic N, Kraut A, Hawlina M, Stunf S, Rothova A (2008 Dec 9) Intermediate uveitis: long-term course and visual outcome. Br J OphthalmolGoogle Scholar
  20. 20.
    Boskovich SA, Lowder CY, Meisler DM, Gutman FA (1993) Systemic diseases associated with intermediate uveitis. Clevel Clin J Med 60:460–465PubMedGoogle Scholar
  21. 21.
    Rothova A, Buitenhuis HJ, Meenken C, Brinkman CJ, Linssen A, Alberts C et al (1992) Uveitis and systemic disease. Br J Ophthalmol 76:137–141CrossRefPubMedGoogle Scholar
  22. 22.
    Graham EM, Edelsten C (1992) Intermediate uveitis and sarcoidosis. Dev Ophthalmol 23:106–110PubMedGoogle Scholar
  23. 23.
    Rodriguez A, Calonge M, Pedroza-Seres, Akova YA, Messmer EM, D’Amico DJ, Foster CS (1996) Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol 114:593–599PubMedGoogle Scholar
  24. 24.
    Zein G, Berta A, Foster CS (2004) Multiple sclerosis-associated uveitis. Ocul Immunol Inflamm 12(2):137–142CrossRefPubMedGoogle Scholar
  25. 25.
    Raja SC, Jabs DA, Dunn JP et al (1999) Pars planitis: clinical features and class II HLA Associations. Ophthalmology 106(3):594–599CrossRefPubMedGoogle Scholar
  26. 26.
    Malinowski SM, Pulido JS, Folk JC (1993) Long-term visual outcome and complications associated with pars planitis. Ophthalmology 100:818–825PubMedGoogle Scholar
  27. 27.
    Tang WM, Pulido JS, Eckels DD et al (1997) The association of HLA-DR15 and intermediate uveitis. Am J Ophthalmol 123:70–75PubMedGoogle Scholar
  28. 28.
    Oruc S, Duffy BF, Mohanakumar T et al (2001) The association of HLA class II with pars planitis. Am J Ophthalmol 131:657–659CrossRefPubMedGoogle Scholar
  29. 29.
    Weber MT, Schmitt C, Weber JC et al (1995) Association of intermediate uveitis with HLA-A28: definition of a new systemic syndrome? Graefes Arch Clin Exp Ophthalmol 233:269–274CrossRefPubMedGoogle Scholar
  30. 30.
    Browning AC, Calladine D, Collins N, Harmer AW, Amoaku WM (2006) HLA typing of a Hong Kong Chinese family with intermediate uveitis. Br J Ophthalmol 90(5):657CrossRefPubMedGoogle Scholar
  31. 31.
    Kaplan HJ (1984) Intermediate uveitis (pars planitis, chronic cyclitis). A four-step approach to treatment. In: Saari KM (ed) Uveitis update. Excerpta Medica, Amsterdam, pp 169–172Google Scholar
  32. 32.
    Forster DJ, Rao NA, Smith RE (1992) Cataract extraction in intermediate uveitis. Dev Ophthalmol 23:204–211 ReviewPubMedGoogle Scholar
  33. 33.
    Helm CJ, Holland GN (1995) The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis. Am J Ophthalmol 120(1):55–64PubMedGoogle Scholar
  34. 34.
    Riordan-Eva P, Lightman S (1994) Orbital floor steroid injections in the treatment of uveitis. Eye 8(Pt 1):66–69PubMedGoogle Scholar
  35. 35.
    Lai WW, Pulido JS (2002) Intermediate uveitis. Ophthalmol Clin North Am 15(3):309–317CrossRefPubMedGoogle Scholar
  36. 36.
    Wakefield D, McCluskey P, Penny R (1986) Intravenous pulse methylprednisolone therapy in severe inflammatory eye disease. Arch Ophthalmol 104:847–851PubMedGoogle Scholar
  37. 37.
    Belfort R Jr, de Abreu MT, Petrilli AM, Kim MK, Martins MC, Lottemberg C, Neves RA, Pavesio CE (1992) Cytotoxic drugs in intermediate uveitis. Dev Ophthalmol 23:171–176 ReviewPubMedGoogle Scholar
  38. 38.
    Nussenblatt RB, Palestine AG (1992) Ciclosporin (Sandimmun) therapy: experience in the treatment of pars planitis and present therapeutic guidelines. Dev Ophthalmol 23:177–184PubMedGoogle Scholar
  39. 39.
    Tugal-Tutkun I, Harvlikova K, Power WJ et al (1996) Changing patterns in uveitis of childhood. Ophthalmology 103:375–383PubMedGoogle Scholar
  40. 40.
    Deane JS, Rosenthal AR (1997) Course and complications of intermediate uveitis. Acta Ophthalmol Scand 75(1):82–84CrossRefPubMedGoogle Scholar
  41. 41.
    Merayo-Lioves J, Power WJ, Rodriguez A, Peroza-Seres M, Forster CS (1999) Secondary glaucoma in patients with uveitis. Ophthalmologica 213:300–304CrossRefGoogle Scholar
  42. 42.
    Lauer AK, Smith JR, Robertson JE, Rosenbaum JT (2002) Vitreous hemorrhage is a common complication of pediatric pars planitis. Ophthalmology 109(1):95–98CrossRefPubMedGoogle Scholar
  43. 43.
    Felder KS, Brockhurst RJ (1982) Neovascular fundus abnormalities in peripheral uveitis. Arch Ophthalmol 100:750–754PubMedGoogle Scholar
  44. 44.
    Arkfeld FD, Brockhurst RJ (1985) Peripapillary subretinal neovascularization in peripheral uveitis. Retina 5:157–160CrossRefPubMedGoogle Scholar
  45. 45.
    Karagiannis DA, Ladas ID (2008) An unusual optic disc neovascularization in a case of intermediate uveitis associated with multiple sclerosis. Eur J Ophthalmol 18(6):1020–1022PubMedGoogle Scholar
  46. 46.
    Vitale AT, Zierhut M, Foster CS (2001) Intermediate uveitis. In: Foster CS, Vitale AT (eds) Diagnosis and treatment of uveitis. WB Saunders Company, Philadelphia, pp 844–857Google Scholar
  47. 47.
    Giles CL (1989) Pediatric intermediate uveitis. J Pediatr Ophthalmol Strabismus 26:136–139PubMedGoogle Scholar
  48. 48.
    Schmidt F (1992) Fluorescein angiography in intermediate uveitis. Dev Ophthalmol 23:139–144PubMedGoogle Scholar
  49. 49.
    Schenck F, Böke W (1988) Fluorescein angiography findings in intermediate uveitis. Klin Monatsbl Augenheilkd 193(3):261–265CrossRefPubMedGoogle Scholar
  50. 50.
    Henderly DE, Haymond RS, Rao NA, Smith RE (1987) The significance of the pars plana exudate in pars planitis. Am J Ophthalmol 103(5):669–671PubMedGoogle Scholar
  51. 51.
    Rothova A, Schulten MSV, Treffers WF, Kijlstra A (1996) Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 80:332–336CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  • Moncef Khairallah
    • 1
  • Kamel Hmidi
    • 1
  • Sonia Attia
    • 1
  • Bechir Jelliti
    • 1
  • Wafa Hasnaoui
    • 1
  • Sonia Zaouali
    • 1
  • Salah Jenzeri
    • 1
  • Salim Ben Yahia
    • 1
  • Riadh Messaoud
    • 1
  1. 1.Department of OphthalmologyFattouma Bourguiba University HospitalMonastirTunisia

Personalised recommendations